GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension.

Study identifies GDF15 as a biomarker-accurately distinguishing PVOD from other PAH forms and predicting outcomes across PVOD, IPAH, and HPAH-advancing earlier diagnosis and personalized treatment.

Publication Details

Journal
Apollo (University of Cambridge)
Published
2025-11-25
DOI
https://doi.org/10.17863/cam.123448
Primary Topic
GDF15 and Related Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension.

Apollo (University of Cambridge)
GDF15 and Related Biomarkers
article

GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension.

article en

Abstract

Study identifies GDF15 as a biomarker-accurately distinguishing PVOD from other PAH forms and predicting outcomes across PVOD, IPAH, and HPAH-advancing earlier diagnosis and personalized treatment.

Apollo (University of Cambridge)
Good health and well-being
Openalex Percentile: Top 33%
GDF15 and Related Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension. · Apollo (University of Cambridge) (2025) | TGRS Research Map | TGRS